These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4991553)

  • 21. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectinomycin as primary treatment of gonorrhea in areas of high prevalence of penicillinase-producing Neisseria gonorrhoeae.
    Berg SW; Harrison WO
    Sex Transm Dis; 1981; 8(1):38-9. PubMed ID: 6452709
    [No Abstract]   [Full Text] [Related]  

  • 23. [In-vitro sensitivity of Neisseria gonorrhoeae against erythromycin and treatment of gonorrhea with Lubomycin B-capsules (author's transl)].
    Müller G; Sönnichsen N
    Dermatol Monatsschr; 1981 Nov; 167(11):672-4. PubMed ID: 6806131
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of cefamandole nafate for the treatment of acute gonococcal salpingitis.
    Hemsell DL; Cunningham FG; Nobles B
    Obstet Gynecol; 1983 May; 61(5):635-40. PubMed ID: 6403898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging threat of untreatable gonococcal infection.
    Duncan S; Duncan CJ
    N Engl J Med; 2012 May; 366(22):2136. PubMed ID: 22646648
    [No Abstract]   [Full Text] [Related]  

  • 26. Cefonicid as therapy for uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae.
    Sanchez PL; Lancaster DJ; Berg SW; Kerbs SB; Harrison WO
    West J Med; 1984 Feb; 140(2):224-6. PubMed ID: 6428048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(41):761-4. PubMed ID: 7565558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of Rifampicin (Rimactan) in the treatment of gonorrhea].
    Szymczykowa B; Jedyńska-Markiewicz B
    Przegl Dermatol; 1976; (6 Suppl):469-71. PubMed ID: 829660
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of gonorrhea with sulmycin].
    Hantschke D; Mauss J
    Z Haut Geschlechtskr; 1970 May; 45(10):407-12. PubMed ID: 4998022
    [No Abstract]   [Full Text] [Related]  

  • 31. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from men with urethritis in Kenya.
    Claeys G; Taelman H; Gichangi P; Tyndall M; Ombete J; Verschraegen G; Temmeperman M
    Sex Transm Infect; 1998 Aug; 74(4):294-5. PubMed ID: 9924474
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
    Tzelepi E; Daniilidou M; Miriagou V; Siatravani E; Pavlidou E; Flemetakis A
    J Antimicrob Chemother; 2008 Sep; 62(3):637-9. PubMed ID: 18556708
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinico-laboratory results of treatment of gonorrhea patients with ampiox].
    Andriasian SG; Anton'eva NA; Danilova TN; Potapnev FV; Skuratovich AA
    Vestn Dermatol Venerol; 1982; (1):29-23. PubMed ID: 6803469
    [No Abstract]   [Full Text] [Related]  

  • 35. Spectinomycin-resistant penicillinase-producing Neisseria gonorrhoeae--California.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 May; 30(19):221-2. PubMed ID: 6454837
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between in vitro quinolone susceptibility of Neisseria gonorrhoeae and outcome of treatment of gonococcal urethritis with single-dose ofloxacin.
    Kam KM; Lo KK; Chong LY; Au WF; Wong PY; Cheung MM
    Clin Infect Dis; 1999 May; 28(5):1165-6. PubMed ID: 10452657
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro activity of several antimicrobial agents against Neisseria gonorrhoeae in the western region of the Kingdom of Saudi Arabia.
    Raddadi AA; Zimmo SK; Abdullah SA
    Sex Transm Infect; 1998 Aug; 74(4):294. PubMed ID: 9924473
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of gonorrhea with spectinomycin].
    Stapiński A; Gede K
    Przegl Dermatol; 1983; 70(2):115-20. PubMed ID: 6227937
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness of a single dose of sisomicin in the treatment of gonorrhea].
    Szarmach H; Poniecka H; Wroński A; Trybuła J; Zaremba A; Niczyporuk W
    Przegl Dermatol; 1980; 67(2):233-7. PubMed ID: 6773110
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sisomicin in the treatment of gonorrhea].
    Szarmach H; Weuta H; Wroński A; Niezyporuk W; Podziewski J; Skarzyński J
    Med Welt; 1983 Jun; 34(25-26):734-5. PubMed ID: 6412032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.